Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 613-624 of 4,306
Drug study icon
CompletedNCT04268303

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
BioXcel Therapeutics Inc
Condition
Schizophrenia
Drug study icon
CompletedNCT00159770

Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Aalborg
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
Switzerland, Denmark, Finland, ...
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT01074632

Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HCl

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Glendale
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT02237235

Effect of MMFS-202-302 on Cognitive Enhancement in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Chicago
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Northwestern University
Condition
Schizophrenia
Drug study icon
CompletedNCT01198353

Effectiveness of Ziprasidone for people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Ansan
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
South Korea
Sponsor
Soonchunhyang University Hospital
Condition
Schizophrenia
Drug study icon
CompletedNCT02137993

A-prexa Compared to Zyprexa for schizophrenia

This study is completed. It is testing A-prexa Compared to Zyprexa for schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 20 Years to 65 Years
Countries
Sponsor
HK inno.N Corporation
Condition
Schizophrenia
Drug study icon
CompletedNCT00061802

Two Atypical Antipsychotics for schizophrenia

This study is completed in the United States, in India, and in Romania. It is testing two Atypical Antipsychotics for schizophrenia.

Multiple locations, including San Diego
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, India, Romania
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.